BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2014 3:13:00 PM | Browse: 594 | Download: 838
Publication Name World Journal of Gastroenterology
Manuscript ID 9731
Country/Territory China
2014-02-26 08:40
Peer-Review Started
2014-02-26 11:50
To Make the First Decision
2014-04-15 19:32
Return for Revision
2014-04-21 19:49
2014-05-11 19:52
Second Decision
2014-06-26 17:09
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-26 17:18
Articles in Press
2014-06-26 17:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-07-18 16:38
Typeset the Manuscript
2014-11-02 17:43
Publish the Manuscript Online
2014-11-17 15:12
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Topic Highlights
Article Title Enteric microbiota leads to new therapeutic strategies for ulcerative colitis
Manuscript Source Invited Manuscript
All Author List Wei-Xu Chen, Li-Hua Ren and Rui-Hua Shi
Funding Agency and Grant Number
Corresponding author Rui-Hua Shi, MD, PhD, Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. ruihuashi@126.com
Keywords Ulcerative colitis; Enteric microbiota; Dysbiosis; Probiotic; Fecal microbiota transplantation; Polyphenol
Core Tip The human gut is comprised of a large, diverse, and dynamic microbiota. The enteric microbiota plays an important role in regulating anti-inflammatory and immunoregulatory activities. An imbalance of the normal enteric microbiota composition, termed dysbiosis, underlies the pathogenesis of ulcerative colitis (UC). Therefore, manipulation of the dysbiosis is an attractive strategy for UC therapy. This review discusses new therapies associated with the regulation of enteric microbiota for UC patients.
Publish Date 2014-11-17 15:12
Citation Chen WX, Ren LH, Shi RH. Enteric microbiota leads to new therapeutic strategies for ulcerative colitis. World J Gastroenterol 2014; 20(42): 15657-15663
Url http://www.wjgnet.com/1007-9327/full/v20/i42/15657.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i42.15657
Full Article (PDF) WJG-20-15657.pdf
Full Article (Word) WJG-20-15657.doc
Manuscript File 9731-Review.docx
Answering Reviewers 9731-Answering reviewers.pdf
Copyright License Agreement 9731-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 9731-Language certificate.pdf
Peer-review Report 9731-Peer review.pdf
Scientific Misconduct Check 9731-CorssCheck.jpg
Scientific Editor Work List 9731-Scientific editor work list.pdf